At 6.7% CAGR, South & Central America Medical Tubing Market is Projected to be worth US$ 1,326.07 million by 2031, says Business Market Insights

According to Business Market Insights’ research, the South & Central America medical tubing market was valued at US$ 790.13 million in 2023 and is expected to reach US$ 1,326.07 million by 2031, registering a CAGR of 6.7% from 2023 to 2031. Tubing with smart technology integration and expanding applications in biopharmaceutical processing are among the critical factors attributed to drive the South & Central America medical tubing market growth.

Smart medical tubing includes sensors that monitor critical parameters such as pressure, flow rate, and temperature, providing healthcare providers with real-time data. This technology allows healthcare providers to track patient conditions more accurately and respond promptly to any anomalies during treatment. In March 2023, Gravitas Medical announced receiving FDA 510(k) clearance for its Entarik System, an enteric feeding tube system and feeding tube. This enteral nutrition delivery system features a "smart" nasogastric tube equipped with sensors that provide information about the location of the tube tip in the stomach. Additionally, sensors and monitors continuously work together to track the tube's position throughout the feeding process. Entarik comes with an intuitive platform that is anticipated to enhance the ability of physicians in intensive care units (ICUs) to access information on time, in turn fostering better decision-making, improving outcomes, and shortening hospital stays.

On the contrary, recalls due to product failure hamper the growth of South & Central America medical tubing market.

By type, the South & Central America medical tubing market is segmented into polyvinyl chloride (PVC), polyimide or nylons, PTFE or thermoplastic elastomers (TPES), thermoplastic polyurethanes (TPUS), polyvinylidene fluoride (PVDF), polypropylene and polyethylene, silicone, and others. The polyvinyl chloride (PVC) segment held 29.7% share of South & Central America medical tubing market share in 2023, amassing US$ 234.53 million. It is projected to garner US$ 392.16 million by 2031 to register 6.6% CAGR during 2023–2031.

In terms of structure, the South & Central America medical tubing market is segmented into single-lumen, multi-lumen, multi-layer extruded tubing, tapered or bump tubing, braided tubing, balloon tubing, corrugated tubing, heat shrink tubing, and others. The single- lumen segment held 19.6% share of South & Central America medical tubing market share in 2023, amassing US$ 154.50 million. It is projected to garner US$ 266.83 million by 2031 to register 7.1% CAGR during 2023–2031.

Based on application, the South & Central America medical tubing market is segmented into bulk disposable tubing, catheters and cannula, drug delivery systems, and others. The bulk disposable tubing segment held 35.0% share of South & Central America medical tubing market share in 2023, amassing US$ 276.35 million. It is projected to garner US$ 468.33 million by 2031 to register 6.8% CAGR during 2023–2031.

By end users, the South & Central America medical tubing market is segmented into hospital and clinics, ambulatory care centers, medical labs, and others. The hospital and clinics segment held 59.6% share of South & Central America medical tubing market share in 2023, amassing US$ 470.60 million. It is projected to garner US$ 787.38 million by 2031 to register 6.6% CAGR during 2023–2031.

Based on country, the South & Central America medical tubing market is categorized into Brazil, Argentina, and      the Rest of South & Central America. Our regional analysis states that Brazil captured 58.5% share of South & Central America medical tubing market in 2023. It was assessed at US$ 462.11 million in 2023 and is likely to hit US$ 772.80 million by 2031, registering a CAGR of 6.6% during 2023–2031.

Key players operating in the medical tubing market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD., among others.

• In October 2024: RAUMEDIC extended its portfolio for biopharmaceutical fluid processing products and launched a new brand for biocompatible tubing. Further, the company expanding its global headquarters with a cutting-edge ISO-7 clean room manufacturing facility. Leveraging more than 70 years of polymer processing expertise, the company is offering its state-of-the-art product range directly to the broader market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com